Wave Life Sciences Ltd.

NASDAQ:WVE   3:59:59 PM EDT
8.81
-0.45 (-4.86%)
Earnings Announcements

Wave Life Sciences Reports Third Quarter 2020 Financial Results And Provides Business Update

Published: 11/09/2020 14:25 GMT
WAVE Life Sciences Ltd (WVE) - Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update.
Wave Life Sciences Ltd - Results From All Cohorts of Precision-hd1 and Precision-hd2 Clinical Trials and Initial Ole Data on Track for 1q 2021.
Wave Life Sciences Ltd - Cash Runway Extended Into 2q 2023.
Wave Life Sciences Ltd - Qtrly Loss per Share $0.86.
Revenue is expected to be $11.17 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $11.08 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.